EA.hy926 Cells and HUVECs Share Similar Senescence Phenotypes but Respond Differently to the Senolytic Drug ABT-263.

Abdelgawad, Ibrahim Y; Agostinucci, Kevin; Ismail, Somia G; Grant, Marianne K O; Zordoky, Beshay N

Abdelgawad, Ibrahim Y; Agostinucci, Kevin; Ismail, Somia G; Grant, Marianne K O; Zordoky, Beshay N.

Afiliação

Abdelgawad IY; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.
Agostinucci K; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.
Ismail SG; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.
Grant MKO; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.
Zordoky BN; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.

Cells ; 11(13)2022 06 21.

Article em En | MEDLINE | ID: mdl-35805077

Assuntos

Proteínas Proto-Oncogênicas c-bcl-2; Senoterapia; Compostos de Anilina; Células Endoteliais da Veia Umbilical Humana; Humanos; Fenótipo; Sulfonamidas

Palavras-chave

ABT-263; BCL-2 family; doxorubicin; endothelial cells; senescence; senolytics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas c-bcl-2 / Senoterapia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cells Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google